Skip to content

Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer

Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036516
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic mass

Interventions

Sponsors

Department of Gastroenterology, Shanghai Changhai hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years, male or female; 2. Diagnosis or suspection of solid pancreatic mass based on previous imaging examination (ultrasonography, CT or MRI); 3. Lesion diameter larger than 1 cm; 4. Signed informed consent letter.

Exclusion criteria

Exclusion criteria: 1. Pregnant female; 2. Pancreatic cystic lesions; 3. Anticoagulant/antiplatelet therapy cannot be suspended; 4. Coagulopathy (platelet count 1.5); 5. Severe cardiopulmonary dysfunction that cannot tolerate intravenous anesthesia; 6. With history of mental disease; 7. Other medical conditions that are not suitable for EUS-FNA.

Design outcomes

Primary

MeasureTime frame
consistency;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactKaixuan Wang

Shanghai Changhai Hospital

wangkaixuan224007@sina.com+86 13585673477

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026